MARKET WIRE NEWS

Kewaunee Scientific to Report Results for Second Quarter Fiscal Year 2026

MWN-AI** Summary

Kewaunee Scientific Corporation (NASDAQ: KEQU), a notable player in the laboratory and technical furniture industry, has announced that it will release its financial results for the second quarter of fiscal year 2026 on December 10, 2025, after trading hours. Investors and stakeholders can access the detailed financial data via the company’s website, www.kewaunee.com.

Founded in 1906, Kewaunee Scientific specializes in designing, manufacturing, and installing a wide array of products tailored for laboratories, healthcare facilities, and technical environments. Their comprehensive product lineup includes steel and wood casework, fume hoods, adaptable modular systems, and various laboratory workstations. The company operates out of its headquarters in Statesville, North Carolina, and has production facilities both domestically and internationally, including a significant presence in Bangalore, India.

A recent strategic acquisition, Nu Aire, enhances Kewaunee's portfolio with a focus on biological safety cabinets and other critical laboratory equipment. Founded in 1971, Nu Aire's facilities in Minnesota further bolster the company's manufacturing capabilities and expand its reach into global markets through partnerships in the Netherlands and China.

As Kewaunee prepares to release its quarterly results, the company acknowledges the potential uncertainties in its business environment. Factors impacting performance include competition, economic conditions, customer demand fluctuations, and reliance on international operations, among others. The company emphasizes the importance of these forward-looking statements and warns that actual outcomes may vary significantly from expectations due to a variety of risk factors.

Overall, this upcoming earnings report will be crucial for investors seeking insight into the company's financial health and growth prospects in a competitive landscape.

MWN-AI** Analysis

As Kewaunee Scientific Corporation prepares to report its second-quarter financial results for fiscal year 2026 on December 10, 2025, investors and market analysts are keenly assessing the implications of this announcement. The company, known for its laboratory and healthcare furniture solutions, recently expanded its portfolio with the acquisition of Nu Aire, a reputable manufacturer of biological safety cabinets and other laboratory products. This strategic move is expected to bolster Kewaunee's existing offerings and drive revenue growth, particularly in burgeoning healthcare markets.

However, potential investors should consider several factors before making investment decisions. Kewaunee's operations are subject to various risks, including supply chain disruptions, fluctuating customer demands, and geopolitical factors. Recent global economic conditions may introduce volatility that could affect the company’s short-term performance. Moreover, the successful integration of Nu Aire will be pivotal; challenges in synergy realization could hinder anticipated benefits.

Analysts should closely monitor Kewaunee’s earnings projections and any commentary on market performance and growth strategies during the upcoming earnings call. Guidance on future revenue expectations, particularly in key segments such as laboratory and healthcare solutions, could provide valuable insights into the company's trajectory.

Investors might also focus on the company's historical performance and recent marketing initiatives as indicators of resilience in competitive environments. While short-term fluctuations are expected, Kewaunee’s established reputation and strategic expansion suggest potential long-term value. Therefore, a cautious approach is advisable for prospective investors—considering both the risks and growth opportunities presented in this evolving market landscape.

**MWN-AI Summary and Analysis is based on asking OpenAI to summarize and analyze this news release.

Source: PR Newswire

PR Newswire

STATESVILLE, N.C., Nov. 26, 2025 /PRNewswire/ -- Kewaunee Scientific Corporation (NASDAQ: KEQU) today announced that the Company plans to release its second quarter fiscal year 2026 financial results on Wednesday, December 10, 2025 after the close of trading. This information will be available on the Company's website www.kewaunee.com after the release.

About Kewaunee Scientific

Founded in 1906, Kewaunee Scientific Corporation is a recognized global leader in the design, manufacture, and installation of laboratory, healthcare, and technical furniture products. The Company's products include steel and wood casework, fume hoods, adaptable modular systems, moveable workstations, stand-alone benches, biological safety cabinets, and epoxy resin work surfaces and sinks. The Company's corporate headquarters are located in Statesville, North Carolina. Sales offices are located in the United States, India, Saudi Arabia, and Singapore. Three manufacturing facilities are located in Statesville serving the domestic and international markets, and one manufacturing facility is located in Bangalore, India serving the local, Asian, and African markets. 

Kewaunee Scientific's newly acquired subsidiary, Nu Aire, is a leading manufacturer of biological safety cabinets, CO2 incubators, ultralow freezers, and other essential laboratory products that complement the Kewaunee Scientific portfolio. Founded in 1971, Nu Aire's headquarters and manufacturing facilities are located in Plymouth, Minnesota, with additional manufacturing capabilities located in Long Lake, Minnesota. The Company also maintains a warehouse partnership in the Netherlands and OEM partnerships in China.

Learn more at the companies' websites, located at http://www.kewaunee.com and http://www.nuaire.com/.  

This press release contains statements that the Company believes to be "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. All statements other than statements of historical fact included in this press release, including statements regarding the Company's future financial condition, results of operations, business operations and business prospects, are forward-looking statements. Words such as "anticipate," "estimate," "expect," "project," "intend," "plan," "predict," "believe" and similar words, expressions and variations of these words and expressions are intended to identify forward-looking statements. Such forward-looking statements are subject to known and unknown risks, uncertainties, assumptions, and other important factors that could significantly impact results or achievements expressed or implied by such forward-looking statements. Such factors, risks, uncertainties and assumptions include, but are not limited to: our ability to realize the benefits anticipated as a result of the Nu Aire acquisition; competitive and general economic conditions, including disruptions from government mandates, both domestically and internationally, as well as supplier constraints and other supply disruptions; changes in customer demands; technological changes in our operations or in our industry; dependence on customers' required delivery schedules; risks related to fluctuations in the Company's operating results from quarter to quarter; risks related to international operations, including foreign currency fluctuations; changes in the legal and regulatory environment; changes in raw materials and commodity costs; acts of terrorism, war, governmental action, and natural disasters and other Force Majeure events. The cautionary statements made pursuant to the Reform Act herein and elsewhere by us should not be construed as exhaustive. We cannot always predict what factors would cause actual results to differ materially from those indicated by the forward-looking statements. Over time, our actual results, performance, or achievements will likely differ from the anticipated results, performance or achievements that are expressed or implied by our forward-looking statements, and such difference might be significant and harmful to our stockholders' interest. Many important factors that could cause such a difference are described under the caption "Risk Factors," in Item 1A of our Annual Report on Form 10-K for the fiscal year ended April 30, 2025, which you should review carefully, and in our subsequent quarterly reports on Form 10-Q and current reports on Form 8-K. These reports are available on our investor relations website at www.kewaunee.com and on the SEC website at www.sec.gov. These forward-looking statements speak only as of the date of this document. The Company assumes no obligation, and expressly disclaims any obligation, to update any forward-looking statements, whether as a result of new information, future events or otherwise.

Contact:     

Donald T. Gardner III


704/871-3274

 

SOURCE Kewaunee Scientific Corporation

FAQ**

What key insights can Kewaunee Scientific Corporation (KEQU) provide about the performance of the newly acquired Nu Aire subsidiary in the upcoming second quarter fiscal year 2026 results?
Kewaunee Scientific Corporation (KEQU)'s upcoming second quarter fiscal year 2026 results may highlight Nu Aire's contributions to revenue growth, integration synergies, and market demand trends, which are critical for assessing overall financial performance and strategic alignment.
How does Kewaunee Scientific Corporation (KEQU) plan to address potential supply chain disruptions and competitive pressures reflected in the forward-looking statements within their report?
Kewaunee Scientific Corporation (KEQU) plans to address potential supply chain disruptions and competitive pressures by increasing operational efficiencies, diversifying suppliers, and enhancing inventory management, as outlined in their forward-looking statements.
Can Kewaunee Scientific Corporation (KEQU) elaborate on any changes in customer demand trends observed during the second quarter and how it may impact their overall financial outlook?
Kewaunee Scientific Corporation (KEQU) has reported a notable shift in customer demand trends during the second quarter, which may positively influence their financial outlook, particularly in the laboratory and healthcare sectors as they adapt to evolving market needs.
What strategies is Kewaunee Scientific Corporation (KEQU) implementing to mitigate risks associated with fluctuating raw material costs and international operations as noted in their cautionary statements?
Kewaunee Scientific Corporation is implementing strategies such as entering into fixed-price supply agreements and diversifying suppliers to mitigate risks from fluctuating raw material costs and international operational challenges, as highlighted in their cautionary statements.

**MWN-AI FAQ is based on asking OpenAI questions about Kewaunee Scientific Corporation (NASDAQ: KEQU).

Kewaunee Scientific Corporation

NASDAQ: KEQU

KEQU Trading

0.0% G/L:

$41.19 Last:

284 Volume:

$41.19 Open:

COSM Ad 300

KEQU Latest News

KEQU Stock Data

$114,368,722
2,307,439
1.48%
10
N/A
Home and Homeware
Consumer Discretionary
US
Statesville

Subscribe to Our Newsletter

Link Market Wire News to Your X Account

Download The Market Wire News App